Display options
Share it on

Front Physiol. 2021 Jun 03;12:673950. doi: 10.3389/fphys.2021.673950. eCollection 2021.

Dysregulation of the Excitatory Renal Reflex in the Sympathetic Activation of Spontaneously Hypertensive Rat.

Frontiers in physiology

Chao Ye, Fen Zheng, Jing-Xiao Wang, Xiao-Li Wang, Qi Chen, Yue-Hua Li, Yu-Ming Kang, Guo-Qing Zhu

Affiliations

  1. Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center of Translational Medicine for Cardiovascular Disease, Department of Physiology, Nanjing Medical University, Nanjing, China.
  2. Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
  3. Department of Physiology and Pathophysiology, Cardiovascular Research Center, Xi'an Jiaotong University School of Medicine, Xi'an, China.

PMID: 34149454 PMCID: PMC8209386 DOI: 10.3389/fphys.2021.673950

Abstract

Excessive sympathetic activation plays crucial roles in the pathogenesis of hypertension. Chemical stimulation of renal afferents increases the sympathetic activity and blood pressure in normal rats. This study investigated the excitatory renal reflex (ERR) in the development of hypertension in the spontaneously hypertensive rat (SHR). Experiments were performed in the Wistar-Kyoto rat (WKY) and SHR aged at 4, 12, and 24 weeks under anesthesia. Renal infusion of capsaicin was used to stimulate renal afferents, and thus, to induce ERR. The ERR was evaluated by the changes in the contralateral renal sympathetic nerve activity and mean arterial pressure. At the age of 4 weeks, the early stage with a slight or moderate hypertension, the ERR was more enhanced in SHR compared with WKY. The pressor response was greater than the sympathetic activation response in the SHR. At the age of 12 weeks, the development stage with severe hypertension, there was no significant difference in the ERR between the WKY and SHR. At the age of 24 weeks, the later stage of hypertension with long-term several hypertensions, the ERR was more attenuated in the SHR compared with the WKY. On the other hand, the pressor response to sympathetic activation due to the ERR was smaller at the age of 12 and 24 weeks than those at the age of 4 weeks. These results indicate that ERR is enhanced in the early stage of hypertension, and attenuated in the later stage of hypertension in the SHR. Abnormal ERR is involved in the sympathetic activation and the development of hypertension.

Copyright © 2021 Ye, Zheng, Wang, Wang, Chen, Li, Kang and Zhu.

Keywords: blood pressure; hypertension; kidney; renal reflex; sympathetic activity

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Int J Mol Sci. 2017 Aug 02;18(8): - PubMed
  2. Cell Death Dis. 2017 Oct 5;8(10):e3074 - PubMed
  3. Am J Physiol Regul Integr Comp Physiol. 2015 Jan 15;308(2):R79-95 - PubMed
  4. Hypertension. 2012 Nov;60(5):1280-6 - PubMed
  5. J Extracell Vesicles. 2019 Dec 2;9(1):1698795 - PubMed
  6. Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1103-11 - PubMed
  7. Hypertension. 1987 Jan;9(1):69-75 - PubMed
  8. Am J Physiol Regul Integr Comp Physiol. 2015 Jan 15;308(2):R112-22 - PubMed
  9. Curr Hypertens Rev. 2019;15(2):144-153 - PubMed
  10. J Am Soc Hypertens. 2016 May;10(5):457-66 - PubMed
  11. Cardiovasc Pathol. 2004 Mar-Apr;13(2):71-8 - PubMed
  12. J Hypertens. 2014 May;32(5):1059-67; discussion 1067 - PubMed
  13. Neurosci Bull. 2020 May;36(5):463-474 - PubMed
  14. Pflugers Arch. 2020 Nov;472(11):1577-1586 - PubMed
  15. Hypertension. 2012 Feb;59(2):367-74 - PubMed
  16. Hypertension. 2007 Mar;49(3):506-10 - PubMed
  17. Exp Physiol. 2010 May;95(5):572-80 - PubMed
  18. Pflugers Arch. 2020 Mar;472(3):325-334 - PubMed
  19. High Blood Press Cardiovasc Prev. 2014 Jun;21(2):89-105 - PubMed
  20. Am J Physiol. 1990 Mar;258(3 Pt 2):F606-11 - PubMed
  21. Gene Ther. 2012 Aug;19(8):810-7 - PubMed
  22. Front Physiol. 2020 Dec 15;11:601237 - PubMed
  23. Pain. 1983 Feb;15(2):109-30 - PubMed
  24. Exp Physiol. 2008 Aug;93(8):945-53 - PubMed
  25. Prog Cardiovasc Dis. 2021 Mar-Apr;65:76-83 - PubMed
  26. Nat Rev Nephrol. 2014 Jun;10(6):305-13 - PubMed
  27. Circ Res. 2015 Mar 13;116(6):976-90 - PubMed
  28. Neurosci Bull. 2020 Feb;36(2):143-152 - PubMed
  29. Acta Physiol (Oxf). 2015 Apr;213(4):778-94 - PubMed
  30. Methods Mol Med. 2005;108:3-15 - PubMed
  31. Acta Physiol (Oxf). 2017 Jan;219(1):288-304 - PubMed
  32. Acta Physiol (Oxf). 2017 May;220(1):11-13 - PubMed
  33. JACC Cardiovasc Interv. 2021 Feb 8;14(3):316-318 - PubMed
  34. Diabetes Nutr Metab. 2000 Dec;13(6):327-31 - PubMed
  35. Exp Physiol. 2010 Jan;95(1):51-5 - PubMed
  36. Am J Physiol Renal Physiol. 2015 Oct 1;309(7):F583-94 - PubMed
  37. Curr Hypertens Rep. 2016 Sep;18(9):69 - PubMed
  38. Exp Physiol. 2011 Feb;96(2):94-103 - PubMed
  39. Hypertension. 2014 Mar;63(3):e25-32 - PubMed
  40. Am J Physiol. 1989 Aug;257(2 Pt 2):F197-203 - PubMed
  41. Hypertension. 2007 Nov;50(5):862-8 - PubMed
  42. Neurosci Bull. 2019 Feb;35(1):1-3 - PubMed

Publication Types